David Chatenet

Structure–activity relationships and structural conformation of a novel urotensin II-related peptide

Hassan Oulyadi, Pierre Renard, Jérôme Leprince, 2004, Peptides.

International Union of Basic and Clinical Pharmacology. XCII. Urotensin II, Urotensin II–Related Peptide, and Their Receptor: From Structure to Function

Jérôme Leprince, Hubert Vaudry, Eliot H. Ohlstein, 2015, Pharmacological Reviews.

Structure–Activity Relationships of Human Urotensin II and Related Analogues on Rat Aortic Ring Contraction

Pierre Renard, Jérôme Leprince, Hubert Vaudry, 2003, Journal of enzyme inhibition and medicinal chemistry.

Urotensin II, from fish to human

Jérôme Leprince, Hubert Vaudry, H. Vaudry, 2010, Annals of the New York Academy of Sciences.

The vasoactive peptides urotensin II and urotensin II-related peptide regulate astrocyte activity through common and distinct mechanisms: involvement in cell proliferation.

Hélène Castel, Pierrick Gandolfo, Jérôme Leprince, 2010, The Biochemical journal.

Update on the urotensinergic system: new trends in receptor localization, activation, and drug design

M. Létourneau, A. Fournier, David Chatenet, 2012, Front. Endocrin..